ZURICH/BERLIN, May 23 (Reuters) - The Swiss blue-chip SMI was seen opening 0.2 percent lower at 9,627 points on Thursday, according to premarket indications by bank Julius Baer .
Here are some of the main factors that may affect Swiss stocks today:
Annual general meeting due.
Novartis AG’s top executive said on Wednesday it expects to price its gene therapy for spinal muscular atrophy “far lower” than the $4 million to $5 million figure the Swiss drugmaker has said it could be worth.
Seperately, the company also said its has 25 potential blockbuster treatments in development, ahead of a management event in the United States on Thursday.
SIX, the Swiss national stock exchange group, is working on creating its own “stablecoin” – a cryptocurrency pegged to the Swiss franc – to facilitate transactions on the SIX Digital Exchange (SDX), CoinDesk reported on Wednesday.
Swiss food group Nestle SA and New Zealand’s dairy producer Fonterra Co-operative Group said they would review strategic options for their Dairy Partners Americas (DPA) joint venture in Brazil, which could include a potential sale.
*Varia US Properties said it successfully issued a 50 million Swiss francs fixed-rate bond.
* Ypsomed Holding reported full year net profit at CHF 60.1 Mln.
* Santhera said it had entered into a licence agreement with Chiesi Group.
Swiss industrial production data for the first quarter due at 0630 GMT. (Reporting by Zurich newsroom and Berlin Speed Desk)